Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 3 homolog (ZFP3) is a member of the C2H2-type zinc finger transcription factors, predicted to function as a DNA-binding transcription factor regulating transcription via RNA polymerase II[3]. ZFP3 contains characteristic zinc finger motifs involved in DNA recognition and is part of the largest family of transcription regulators in the human genome[2][3]. In model organisms, ZFP3 homologs are associated with transcriptional responses to environmental stress or development, but for the human ortholog, strong evidence for a direct functional or disease role is limited. There are no known drug interactions or uses as a clinical biomarker, and ZFP3 itself is not currently recognized as a therapeutic target or disease-associated gene in humans[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 3 homolog (ZFP3).